Allied Biotech Corporation (TPEX:1780)
Taiwan · Delayed Price · Currency is TWD 26.95
-1.45 (-5.11%)
Jun 18, 2026, 1:30 PM CST
Allied Biotech Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,594 | 2,223 | 1,666 | 1,580 | 1,340 | 1,454 | |
Market Cap Growth | 49.23% | 33.45% | 5.41% | 17.93% | -7.84% | -9.31% |
Enterprise Value | 2,467 | 2,176 | 1,603 | 1,584 | 1,422 | 1,463 |
Last Close Price | 26.95 | 22.22 | 15.81 | 14.34 | 11.40 | 11.93 |
PE Ratio | 24.29 | 17.17 | 16.51 | 16.22 | 9.13 | 111.49 |
PS Ratio | 2.95 | 2.62 | 2.07 | 2.19 | 1.87 | 2.15 |
PB Ratio | 2.04 | 1.80 | 1.39 | 1.35 | 1.13 | 1.35 |
P/TBV Ratio | 2.04 | 1.80 | 1.39 | 1.35 | 1.13 | 1.35 |
P/FCF Ratio | 29.41 | 17.42 | 8.46 | 17.62 | 12.23 | 64.80 |
P/OCF Ratio | 14.09 | 10.24 | 7.44 | 11.48 | 8.16 | 20.08 |
EV/Sales Ratio | 2.80 | 2.56 | 1.99 | 2.20 | 1.98 | 2.16 |
EV/EBITDA Ratio | 12.86 | 12.38 | 11.11 | 10.40 | 8.61 | 8.58 |
EV/EBIT Ratio | 18.86 | 18.08 | 18.19 | 17.86 | 14.25 | 13.10 |
EV/FCF Ratio | 27.97 | 17.05 | 8.14 | 17.66 | 12.98 | 65.19 |
Debt / Equity Ratio | 0.57 | 0.59 | 0.80 | 0.68 | 0.71 | 1.15 |
Debt / EBITDA Ratio | 3.78 | 4.04 | 6.36 | 5.03 | 4.88 | 7.03 |
Debt / FCF Ratio | 8.23 | 5.74 | 4.84 | 8.87 | 7.64 | 55.38 |
Net Debt / Equity Ratio | -0.10 | -0.10 | -0.03 | 0.06 | 0.04 | 0.09 |
Net Debt / EBITDA Ratio | -0.68 | -0.69 | -0.23 | 0.46 | 0.27 | 0.58 |
Net Debt / FCF Ratio | -1.43 | -0.96 | -0.17 | 0.79 | 0.40 | 4.39 |
Asset Turnover | 0.39 | 0.39 | 0.37 | 0.34 | 0.31 | 0.29 |
Inventory Turnover | 1.10 | 1.04 | 0.97 | 0.79 | 0.81 | 0.84 |
Quick Ratio | 1.18 | 1.24 | 1.12 | 1.01 | 1.02 | 0.93 |
Current Ratio | 1.79 | 1.90 | 1.67 | 1.76 | 1.72 | 1.33 |
Return on Equity (ROE) | 8.46% | 10.65% | 8.54% | 8.28% | 12.96% | 1.17% |
Return on Assets (ROA) | 3.63% | 3.46% | 2.54% | 2.60% | 2.70% | 2.97% |
Return on Invested Capital (ROIC) | 9.07% | 8.34% | 5.70% | 5.72% | 6.57% | 7.00% |
Return on Capital Employed (ROCE) | 9.90% | 9.30% | 7.00% | 7.10% | 7.70% | 10.20% |
Earnings Yield | 4.13% | 5.82% | 6.06% | 6.16% | 10.95% | 0.90% |
FCF Yield | 3.40% | 5.74% | 11.82% | 5.68% | 8.18% | 1.54% |
Dividend Yield | 4.64% | 5.63% | 6.32% | 5.93% | 10.52% | 4.19% |
Payout Ratio | 89.61% | 74.17% | 80.66% | 117.50% | 32.49% | 583.66% |
Buyback Yield / Dilution | 0.11% | -0.10% | -0.37% | -0.20% | -0.43% | -0.05% |
Total Shareholder Return | 4.51% | 5.53% | 5.95% | 5.73% | 10.09% | 4.14% |